Treatment Preparation for Bone Metastases Before Initiating Bone-Targeted Agent Therapy
Clinical Context
Patients with bone metastases who are candidates for bone-targeted agent (BTA) therapy require structured preparatory management before treatment begins. Addressing nutritional status and oral health is an essential first step in the protocol.
Treatment Approach (partial)
The protocol involves correction of nutritional deficiencies — including vitamin D and calcium — and a mandatory oral and dental evaluation prior to starting bone-targeted agent therapy. The timing, sequencing, and full monitoring plan are detailed in the complete protocol.
Specific supplementation thresholds, dental requirements, and ongoing monitoring guidance are available in the full structured regimen.
Treatment Goals
The primary clinical objectives are achieving normal serum calcium levels and maintaining adequate serum vitamin D levels throughout treatment.
References
DOI: 10.1016/j.annonc.2020.07.019
- Vitamin D levels are typically low in cancer patients and those with vitamin D deficiency should have their levels corrected with oral vitamin D3 (25‑50 000 IU per week for 4‑8 weeks).
- Vitamin D levels should be maintained with daily supplements (800‑2000 IU per day) of vitamin D3.
- Calcium supplementation may also be required to ensure an adequate daily intake of 1000‑1200 mg per day.
- If a calcium-enriched diet is not sufficient to ensure the uptake of 1000‑1200 mg calcium per day, a supplementation of 500‑1000 mg is recommended.
- Before BTA therapy is initiated, an oral examination and appropriate preventive dentistry are strongly recommended.
- Patients should avoid invasive dental procedures (extractions and implants) during therapy if possible, maintain good oral hygiene and ensure regular dental/oral surgery review.
- Calcium levels should be monitored, especially during the first few months of treatment and vitamin D levels assessed before starting treatment.
- Correction of vitamin D deficiency and vitamin D supplementation with adequate intake of calcium throughout treatment to maintain normal serum calcium are recommended.
View source ↗